e-learning
resources
Paris 2018
Tuesday, 18.09.2018
How far are we in terms of predicting mortality and exacerbations in COPD?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD exacerbation phenotypes in a five year hospitalisation cohort
S. Brill (Lon, United Kingdom), T. Jones (Lon, United Kingdom), J. Brown (Lon, United Kingdom), J. Hurst (Lon, United Kingdom), R. Vancheeswaran (Lon, United Kingdom)
Source:
International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Session:
How far are we in terms of predicting mortality and exacerbations in COPD?
Session type:
Poster Discussion
Number:
3863
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Brill (Lon, United Kingdom), T. Jones (Lon, United Kingdom), J. Brown (Lon, United Kingdom), J. Hurst (Lon, United Kingdom), R. Vancheeswaran (Lon, United Kingdom). COPD exacerbation phenotypes in a five year hospitalisation cohort. 3863
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Predictors of mortality in COPD patients after hospitalization due to an exacerbation
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Factors affecting one year mortality of hospitalized patients with COPD exacerbation and respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 321s
Year: 2007
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011
Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
One year experience with acute COPD assessment service (ACAS) for patients with acute exacerbations of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 178s
Year: 2006
The main reasons of exacerbation and hospitalization of COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 558s
Year: 2007
Determinants of 6-months mortality in elderly patients admitted for non-acidotic acute exacerbation of COPD (AECOPD)
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007
Trends in the lifetime risk of COPD exacerbation requiring hospitalisation
Source: Eur Respir J 2013; 42: 964-971
Year: 2013
The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013
Community follow-up of COPD patients following admission for exacerbation
Source: Eur Respir J 2003; 22: Suppl. 45, 244s
Year: 2003
Non-invasive ventilation (NIV) and mortality in patients with a first-time admission for a COPD exacerbation: A nationwide study
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
An observational study of risk factors for hospitalization of chronic obstructive pulmonary disease exacerbation and their outcome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Survival in COPD patients with hospitalization due to exacerbation
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Effect of screening for undiagnosed COPD on respiratory hospitalisation and mortality; 4 year follow up of the TargetCOPD trial
Source: International Congress 2019 – Management of airway diseases in primary care
Year: 2019
Influence of previous admissions on audit outcomes in patients admitted with acute exacerbation of COPD (AECOPD)
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept